Editorial
DOI:
https://doi.org/10.32350/BSR.51.i1Keywords:
COVID-19, DELTA, SARS, MERS, PCR, VACCINESAbstract
The global epidemic of coronavirus disease 2019 (COVID-19) has presented a major threat to public health worldwide. The causal agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [a member of Severe acute respiratory syndrome-related coronavirus] that was first isolated and identified in patients who were exposed at a seafood market in Wuhan City, Hubei Province, China on December 2019. The COVID-19 epidemic represents a substantial challenge for governments, individuals, and society as a whole.
Downloads
Published
How to Cite
Issue
Section
License
BSR follows an open-access publishing policy and full text of all published articles is available free, immediately upon publication of an issue. The journal’s contents are published and distributed under the terms of the Creative Commons Attribution 4.0 International (CC-BY 4.0) license. Thus, the work submitted to the journal implies that it is original, unpublished work of the authors (neither published previously nor accepted/under consideration for publication elsewhere). On acceptance of a manuscript for publication, a corresponding author on the behalf of all co-authors of the manuscript will sign and submit a completed the Copyright and Author Consent Form.
